How to Evaluate the Benefit-Risk Profile of Newly Marketed Drugs
Annales de dermatologie et de vénéréologie 2010 Apr; 137(4): 264-6, 261-3
Showing items related by title, author, creator and subject.
Is It Ethical Conducting Placebo-Controlled Clinical Trials as Part of the Development of New Drugs for the Treatment of Major Depressive Disorder? (And II). Benefit/risk Ratio and Informed Consent. Conclusions Lahuerta, Juan; Gracia, Diego; Casas, Miquel; Baca, Enrique (2004-10-30)